AI-generated summary
The authors randomized 100 patients with facial atrophic acne scars to a 2 940 nm fractional erbium laser alone or combined with fractional micro-plasma radiofrequency, and 89 completed the study. The authors report that the combination group had significantly lower ECCA scar scores after the second and third treatments and higher patient satisfaction, with no significant difference in adverse reactions.
- Participants
- 89
- Who or what was studied
- Adults aged 18 to 37 with facial atrophic acne scars treated at a single hospital in Shanghai
- Limits stated in the abstract
- The abstract does not describe blinding or allocation concealment, and 11 of the 100 enrolled patients did not complete the study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.